{"id":"daec9454-4e34-593b-833e-9f2450798ff0","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:intraduodenal-nattokinase-prolongs-plasma-recalcification-time","predicate":"increases","statement":"In parallel with the fibrinogen degradation, plasma recalcification time was prolonged.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"f139bddb-40d0-503b-88bf-5d6dca3f6e34","mechanism_event_label":"In parallel with the fibrinogen degradation, plasma recalcification time was prolonged.","subject":{"id":"6b03a125-209a-5060-8b35-ec9e0e54033c","slug":"nattokinase","display_name":"Nattokinase / subtilisin NAT","entity_type_key":"peptide"},"object":{"id":"9ce14493-6622-5d65-a240-1274f743c5a9","slug":"plasma-recalcification-time","display_name":"Plasma recalcification time","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"f139bddb-40d0-503b-88bf-5d6dca3f6e34","stable_key":"33bef151-bdc7-5892-aff6-0345ab149739:intraduodenal-nattokinase-prolongs-plasma-recalcification-time-event","event_type":"observed_intervention","label":"In parallel with the fibrinogen degradation, plasma recalcification time was prolonged.","description":"Femoral-vein plasma","status":"provisional","compartment":null,"participants":[{"entity":{"id":"6b03a125-209a-5060-8b35-ec9e0e54033c","slug":"nattokinase","display_name":"Nattokinase / subtilisin NAT","entity_type_key":"peptide"},"role":"acting component","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"9ce14493-6622-5d65-a240-1274f743c5a9","slug":"plasma-recalcification-time","display_name":"Plasma recalcification time","entity_type_key":"cellular_process"},"role":"component the finding is about","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""}]},"contexts":[{"dimension":"duration","value_text":"Sampling to 5 h","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"evidence_access","value_text":"Primary PubMed abstract and indexed metadata reviewed. Full-text method details not stated here remain unresolved.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Rat (male Wistar, n = 20)","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Nattokinase 80 mg/kg","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Uncontrolled, and a functional consequence of the same uncontrolled experiment rather than independent support for it.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"organism","value_text":"Rat (male Wistar, n = 20)","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"In parallel with the fibrinogen degradation, plasma recalcification time was prolonged.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"Transport of nattokinase across the rat intestinal tract. (1995) https://pubmed.ncbi.nlm.nih.gov/8845803/ DOI: 10.1248/bpb.18.1194","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"route","value_text":"In vivo, intraduodenal into a ligated loop","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue","value_text":"Femoral-vein plasma","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"d9d2ccd8-9160-560f-bef9-bc13de844e61","evidence_kind":"source_excerpt","locator":"Lines 763-763","start_line":763,"end_line":763,"excerpt":"In parallel with the fibrinogen degradation, plasma recalcification time was prolonged.","model_system":"Rat (male Wistar, n = 20)","directness":"reported_statement","verification_status":"source_derived_draft","notes":"","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"41cb127c-1c23-53aa-b7d0-5ec7f6fa3c99","stable_key":"import-33bef151-bdc7-5892-aff6-0345ab149739","title":"Nattokinase: what the purified enzyme cleaves, what survives being eaten, and the gap between the two (2026-09-23)","document_type":"imported_text","citation_label":"Original AI-assisted curation built from a supplied entity-first document of 105 entities and 129 claims. Every reference in that document was resolved against live PubMed with its abstract read and its DOI cross-checked on 2026-09-23, and the EFSA novel-food opinion was retrieved and read in full. That check corrected two PMIDs that pointed at unrelated papers, two DOIs, and two papers recorded as carrying no erratum that do carry one; it also reversed three findings the supplied document had stated backwards. Two papers carry a published correction, recorded as such and not as a retraction. Three sources are not indexed in PubMed and are cited by what they have. Laboratory lineages are recorded, so the four papers from one group, the three from another and the two readings of a single applicant dossier cannot be counted as separate lines of support. Study-specific doses, units, populations and limitations retained; activity units are never converted between systems. Not publisher full text.","file_path":"","sha256":"34fc46e0e849d06bfa13cb099a79b50679dd6fd0de8a5a0575326afdde3259c1","revision_id":"efd063e6-e982-5f6e-a4b8-6f2ffe4185ce","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}